Literature DB >> 7982869

Prediction of response to methylphenidate among children with ADHD and mental retardation.

B L Handen1, J Janosky, S McAuliffe, A M Breaux, H Feldman.   

Abstract

OBJECTIVE: The primary purpose of this study was to predict stimulant medication response among children with attention-deficit hyperactivity disorder (ADHD) and mental retardation (MR).
METHOD: Forty-seven children with ADHD and MR (IQs of 48 to 77) served as subjects; ages ranged from 6.1 to 12.5 years. Subjects participated in a double-blind, placebo-controlled study of two doses of methylphenidate (0.3 and 0.6 mg/kg per dose) and a placebo. Data were collected in each child's weekday classroom and a Saturday laboratory classroom. Stepwise multiple regression analyses were used to predict drug responses in both settings.
RESULTS: Higher parent ratings of impulsivity and activity level at baseline were associated with greater gains in weekday classroom dependent measures. Similarly, higher weekday teacher measures of activity level, impulsivity, inattention, and conduct problems at baseline were related to improvement on Saturday laboratory classroom dependent measures. Finally, gender, race, and socioeconomic status (SES) were found to be important predictors, with males, Caucasian subjects, and subjects from families of higher SES more likely to evidence clinical gains on a number of variables than other subjects.
CONCLUSION: These results were generally consistent with research conducted among children with ADHD but without MR. However, factors such as race and conduct problems appear to have predictive utility specific to children with MR.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7982869     DOI: 10.1097/00004583-199410000-00014

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  6 in total

1.  Population pharmacodynamic modeling of various extended-release formulations of methylphenidate in children with attention deficit hyperactivity disorder via meta-analysis.

Authors:  Holly Kimko; Ekaterina Gibiansky; Leonid Gibiansky; H Lynn Starr; Joris Berwaerts; Joseph Massarella; Frank Wiegand
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-01-22       Impact factor: 2.745

2.  Long-term follow-up of children with mental retardation/borderline intellectual functioning and ADHD.

Authors:  B L Handen; J Janosky; S McAuliffe
Journal:  J Abnorm Child Psychol       Date:  1997-08

Review 3.  Attention deficit hyperactivity disorder--a review.

Authors:  C Williams; B Wright; I Partridge
Journal:  Br J Gen Pract       Date:  1999-07       Impact factor: 5.386

4.  Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder.

Authors:  B L Handen; C R Johnson; M Lubetsky
Journal:  J Autism Dev Disord       Date:  2000-06

Review 5.  Toward Precision Medicine in ADHD.

Authors:  Jan Buitelaar; Sven Bölte; Daniel Brandeis; Arthur Caye; Nina Christmann; Samuele Cortese; David Coghill; Stephen V Faraone; Barbara Franke; Markus Gleitz; Corina U Greven; Sandra Kooij; Douglas Teixeira Leffa; Nanda Rommelse; Jeffrey H Newcorn; Guilherme V Polanczyk; Luis Augusto Rohde; Emily Simonoff; Mark Stein; Benedetto Vitiello; Yanki Yazgan; Michael Roesler; Manfred Doepfner; Tobias Banaschewski
Journal:  Front Behav Neurosci       Date:  2022-07-06       Impact factor: 3.617

6.  A playroom observation procedure to assess children with mental retardation and ADHD.

Authors:  B L Handen; S McAuliffe; J Janosky; H Feldman; A M Breaux
Journal:  J Abnorm Child Psychol       Date:  1998-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.